Quest’s stock gains after announcing diagnostics that test for both COVID-19 and the flu

/ / News

Shares of Quest Diagnostics Inc. gained 3.1% in premarket trading on Wednesday after the company said it is now offering three panel tests that can detect COVID-19 as well as other respiratory infections, like the flu. Instead of ordering separate tests, a health care provider can now use a single specimen to test for different respiratory infections, “for potentially improved patient care,” Quest said. Quest is selling a Roche Holding AG’s panel test that can detect flu and COVID-19, as well as two of its own panel tests that test for coronavirus infections as well as other respiratory infections. Quest’s stock is up 6.4% for the year, while the S&P 500 has gained 3.2%.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.